The structural heart market is one of the fastest growing medical-device fields. The market’s growth has accelerated with the rise of the Transcatheter Mitral Valve repair (TMVr) treatments, and more specifically Transcatheter Edge-to-Edge Repair (TEER), which is already a multibillion-dollar market. Mitral regurgitation (MR), or leakage of the heart’s mitral valve, affects millions of people, but only a small percentage are treated. As technologies advance and accessibility to treatment goes up, the demand for mitral valve repairs will greatly increase.